Affiliation:
1. Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905 , USA
2. Department of Quantitative Health Sciences and Biostatistics, Mayo Clinic , Rochester, MN 55905 , USA
Abstract
Abstract
Background and Aims
Incidence and types of secondary tricuspid regurgitation (TR) are not well defined in atrial fibrillation (AFib) and sinus rhythm (SR). Atrial secondary TR (A-STR) is associated with pre-existing AFib; however, close to 50% of patients with A-STR do not have AFib. The aim of this study was to assess incidence, types, and outcomes of ≥ moderate TR in AFib vs. SR.
Methods
Adults with and without new-onset AFib without structural heart disease or ≥ moderate TR at baseline were followed for the development of ≥ moderate TR. Tricuspid regurgitation types were pacemaker, left-sided valve disease, left ventricular (LV) dysfunction, pulmonary hypertension (PH), isolated ventricular, and A-STR.
Results
Among 1359 patients with AFib and 20 438 in SR, 109 and 378 patients developed ≥ moderate TR, respectively. The individual types of TR occurred more frequently in AFib related to the higher pacemaker implantation rates (1.12 vs. 0.19 per 100 person-years, P < .001), larger right atrial size (median 78 vs. 53 mL, P < .001), and higher pulmonary pressures (median 30 vs. 28 mmHg, P < .001). The most common TR types irrespective of rhythm were LV dysfunction-TR and A-STR. Among patients in SR, those with A-STR were older, predominantly women with more diastolic abnormalities and higher pulmonary pressures. All types of secondary TR were associated with all-cause mortality, highest in PH-TR and LV dysfunction-TR.
Conclusions
New-onset AFib vs. SR conferred a higher risk of the individual TR types related to sequelae of AFib and higher pacemaker implantation rates, although the distribution of TR types was similar. Secondary TR was universally associated with increased mortality.
Publisher
Oxford University Press (OUP)
Reference51 articles.
1. Tricuspid regurgitation;Hahn;N Engl J Med,2023
2. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome;Hahn;Eur Heart J Cardiovasc Imaging,2022
3. 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS);Vahanian;Rev Esp Cardiol (Engl Ed),2022
4. Tricuspid and mitral remodelling in atrial fibrillation: a three-dimensional echocardiographic study;Ortiz-Leon;Eur Heart J Cardiovasc Imaging,2022
5. Clinical context and mechanism of functional tricuspid regurgitation in patients with and without pulmonary hypertension;Topilsky;Circ Cardiovasc Imaging,2012
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献